These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11193839)

  • 1. Molecular cloning, mRNA distribution and pharmacological characterization of a VIP/PACAP receptor in the frog Rana ridibunda.
    Alexandre D; Anouar Y; Jégou S; Fournier A; Vaudry H
    Ann N Y Acad Sci; 2000; 921():300-3. PubMed ID: 11193839
    [No Abstract]   [Full Text] [Related]  

  • 2. A cloned frog vasoactive intestinal polypeptide/pituitary adenylate cyclase-activating polypeptide receptor exhibits pharmacological and tissue distribution characteristics of both VPAC1 and VPAC2 receptors in mammals.
    Alexandre D; Anouar Y; Jegou S; Fournier A; Vaudry H
    Endocrinology; 1999 Mar; 140(3):1285-93. PubMed ID: 10067855
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receptors and transcriptional factors involved in the anti-inflammatory activity of VIP and PACAP.
    Leceta J; Gomariz RP; Martinez C; Abad C; Ganea D; Delgado M
    Ann N Y Acad Sci; 2000; 921():92-102. PubMed ID: 11193883
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression and coupling of PACAP/VIP receptors in cortical neurons and type I astrocytes.
    Grimaldi M; Cavallaro S
    Ann N Y Acad Sci; 2000; 921():312-6. PubMed ID: 11193842
    [No Abstract]   [Full Text] [Related]  

  • 5. Pituitary adenylate cyclase-activating peptide stimulates acute progesterone production in rat granulosa/Lutein cells via two receptor subtypes.
    Gräs S; Hedetoft C; Pedersen SH; Fahrenkrug J
    Biol Reprod; 2000 Jul; 63(1):206-12. PubMed ID: 10859261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel splice variants of type I pituitary adenylate cyclase-activating polypeptide receptor in frog exhibit altered adenylate cyclase stimulation and differential relative abundance.
    Alexandre D; Vaudry H; Grumolato L; Turquier V; Fournier A; Jégou S; Anouar Y
    Endocrinology; 2002 Jul; 143(7):2680-92. PubMed ID: 12072402
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The effect of pituitary adenylate cyclase activating polypeptide on cultured rat cardiocytes as a cardioprotective factor.
    Sano H; Miyata A; Horio T; Nishikimi T; Matsuo H; Kangawa K
    Regul Pept; 2002 Nov; 109(1-3):107-13. PubMed ID: 12409222
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Receptors for vasoactive intestinal peptide and pituitary adenylate cyclase-activating polypeptide in turkey cerebral cortex: characterization by [125I]-VIP binding and effects on cyclic AMP synthesis.
    Zawilska JB; Niewiadomski P; Nowak JZ
    Gen Comp Endocrinol; 2004 Jun; 137(2):187-95. PubMed ID: 15158130
    [TBL] [Abstract][Full Text] [Related]  

  • 9. VIP1 and VIP2 receptors but not PVR1 mediate the effect of VIP/PACAP on cytokine production in T lymphocytes.
    Jiang X; Wang HY; Yu J; Ganea D
    Ann N Y Acad Sci; 1998 Dec; 865():397-407. PubMed ID: 9928038
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Vasoactive intestinal peptide and pituitary adenylyl cyclase-activating polypeptide inhibit tumor necrosis factor-alpha production in injured spinal cord and in activated microglia via a cAMP-dependent pathway.
    Kim WK; Kan Y; Ganea D; Hart RP; Gozes I; Jonakait GM
    J Neurosci; 2000 May; 20(10):3622-30. PubMed ID: 10804204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoactive intestinal peptide (VIP)/pituitary adenylate cyclase-activating peptide receptor subtypes in mouse calvarial osteoblasts: presence of VIP-2 receptors and differentiation-induced expression of VIP-1 receptors.
    Lundberg P; Lundgren I; Mukohyama H; Lehenkari PP; Horton MA; Lerner UH
    Endocrinology; 2001 Jan; 142(1):339-47. PubMed ID: 11145597
    [TBL] [Abstract][Full Text] [Related]  

  • 12. VPAC2-R mediates the lipolytic effects of pituitary adenylate cyclase-activating polypeptide/vasoactive intestinal polypeptide in primary rat adipocytes.
    Akesson L; Ahrén B; Edgren G; Degerman E
    Endocrinology; 2005 Feb; 146(2):744-50. PubMed ID: 15514088
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evidence for roles of vasoactive intestinal polypeptide (VIP) and pituitary adenylate cyclase activating polypeptide (PACAP) receptors in modulating the responses of rat dorsal horn neurons to sensory inputs.
    Dickinson T; Fleetwood-Walker SM; Mitchell R; Lutz EM
    Neuropeptides; 1997 Apr; 31(2):175-85. PubMed ID: 9179871
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pituitary adenylate cyclase-activating polypeptide receptors mediating insulin secretion in rodent pancreatic islets are coupled to adenylate cyclase but not to PLC.
    Jamen F; Puech R; Bockaert J; Brabet P; Bertrand G
    Endocrinology; 2002 Apr; 143(4):1253-9. PubMed ID: 11897681
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pituitary adenylate cyclase activating polypeptide (PACAP) and vasoactive intestinal peptide (VIP) stimulate interleukin-6 production through the third subtype of PACAP/VIP receptor in rat bone marrow-derived stromal cells.
    Cai Y; Xin X; Shim GJ; Mokuno Y; Uehara H; Yamada T; Agui T; Matsumoto K
    Endocrinology; 1997 Jun; 138(6):2515-20. PubMed ID: 9165043
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Heterogeneity of pituitary adenylate cyclase-activating polypeptide and vasoactive intestinal polypeptide receptors in rat intrinsic cardiac neurons.
    DeHaven WI; Cuevas J
    Neurosci Lett; 2002 Aug; 328(1):45-9. PubMed ID: 12123856
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Distribution of PACAP receptor mRNAs and PACAP binding sites in the rat brain during development.
    Basille M; Vaudry D; Coulouarn Y; Jégou S; Lihrmann I; Fournier A; Vaudry H; Gonzalez BJ
    Ann N Y Acad Sci; 2000; 921():304-7. PubMed ID: 11193840
    [No Abstract]   [Full Text] [Related]  

  • 18. Neuroendocrine differentiation of the LNCaP prostate cancer cell line maintains the expression and function of VIP and PACAP receptors.
    Juarranz MG; Bolaños O; Gutiérrez-Cañas I; Lerner EA; Robberecht P; Carmena MJ; Prieto JC; Rodríguez-Henche N
    Cell Signal; 2001 Dec; 13(12):887-94. PubMed ID: 11728828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distribution of mRNAs for pituitary adenylate cyclase-activating polypeptide (PACAP), PACAP receptor, vasoactive intestinal polypeptide (VIP), and VIP receptors in the rat superior cervical ganglion.
    Nogi H; Hashimoto H; Hagihara N; Shimada S; Yamamoto K; Matsuda T; Tohyama M; Baba A
    Neurosci Lett; 1997 May; 227(1):37-40. PubMed ID: 9178853
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pituitary adenylate cyclase-activating polypeptide and its receptors: from structure to functions.
    Vaudry D; Gonzalez BJ; Basille M; Yon L; Fournier A; Vaudry H
    Pharmacol Rev; 2000 Jun; 52(2):269-324. PubMed ID: 10835102
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.